ESAs and Death Risk

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
147 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon
Ratings have been disabled for this video.

Uploaded by on Dec 23, 2008

ESAs and Death Risk Dr. Julia Bohlius and Dr. Andreas Engert discuss findings that cancer patients on erythropoiesis-stimulating agents are 17% more likely to die of any cause while in clinical trials. Jane MacNeil of Elsevier Global Medical News (EGMN) reports from the annual meeting of the American Society of Hematology.

Category:

News & Politics

Tags:

License:

Standard YouTube License

All Comments

Adding comments has been disabled for this video.

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more